EUVIMEDEUVIMED entdecken
Crossref

Total synthesis of a novel C9-monoterpenoid alkaloid, Forsyqinlingine C, and its therapeutic potential in sepsis-induced acute lung injury via modulation of the TLR4/TRIF/NF-κB pathway

Jianzeng Xin, Yupei Sun, Shuai Huang, Pufan Yang, Xiaofeng Mou, Shengjun Dai, Yuan Du, Sheng Liu

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Jianzeng Xin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yantai Key Laboratory of Characteristic Agricultural Bioresource Conservation & Germplasm Innovative Utilization, School of Life Sciences, Yantai Uni…. Hauptthemen laut MEDLINE: Acute Lung Injury, Alkaloids, Anti-Inflammatory Agents, Sepsis. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Yantai University, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis-induced acute lung injury (ALI) is a critical health concern with high morbidity and mortality, while its effective treatment options are limited. Our previous study, identified forsyqinlingine C (FC), a novel C9-monoterpenoid alkaloid from the ripe fruit of Forsythia suspensa (Thunb.) Vahl, exhibits notable anti-inflammatory activity. In this study, we reported the total synthesis of FC and its therapeutic potential against sepsis-induced ALI for the first time. The target compound was achieved in four steps, including barbier reaction, heck reaction, hydroxyl reduction and hydroboration oxidation, with impressive combined yields of 45 % and high purity of 95 %. In biological study, an inflammatory cell model and a murine model of sepsis-induced ALI were established to explore the potential protective effect of FC and its underlying mechanisms. Our findings indicated that FC could inhibit the expression levels of TLR4, TRIF, p-NF-κB p65, and p-IκB-α and reduce the production of downstream inflammatory cytokine (IL-6 and TNF-α) in MLE-12 cells. In vivo, FC significantly alleviates LPS-induced lung injury by reducing MPO levels, and lung W/D ratios, and ameliorating histopathological alterations. FC also decreased TNF-α and IL-6 production induced by LPS in the murine serum, BALF, and lung tissue in a dose-dependent manner. Meanwhile, FC inhibited the expression levels of TLR4, TRIF, p-NF-κB p65, and p-IκB-α, which are activated by LPS administration. Furthermore, molecular docking studies results speculated that FC could disturb the TLR4/TRIF signaling pathway. In conclusion, FC demonstrated potential in alleviating sepsis-induced ALI, primarily by inhibiting LPS-stimulated inflammatory response through the TLR4/TRIF/NF-κB signaling pathway. This research offers an alternative treatment for sepsis-induced ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryAlkaloidsAnti-Inflammatory AgentsSepsisMonoterpenesAnimalsMaleMiceAdaptor Proteins, Vesicular TransportDose-Response Relationship, DrugLipopolysaccharidesMice, Inbred C57BLMolecular StructureNF-kappa BSignal TransductionStructure-Activity RelationshipToll-Like Receptor 4

Stichwörter der Autor:innen

Forsyqinlingine CInflammationSepsis-induced acute lung injuryTotal synthesis

Substanzen

Adaptor Proteins, Vesicular TransportAlkaloidsAnti-Inflammatory AgentsLipopolysaccharidesNF-kappa BToll-Like Receptor 4MonoterpenesTicam1 protein, mouseTlr4 protein, mouse

Autor:innen und Institutionen

  • Yantai Key Laboratory of Characteristic Agricultural Bioresource Conservation & Germplasm Innovative Utilization, School of Life Sciences, Yantai University, Yantai 264005, PR China.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China.
  • Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: sjdai8616@sina.com.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: adua8888@163.com.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: liusheng87@126.com.

Förderung

  • Yantai University
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Xin, J., Sun, Y., Huang, S., Yang, P., Mou, X., Dai, S., Du, Y., & Liu, S. (2025). Total synthesis of a novel C9-monoterpenoid alkaloid, Forsyqinlingine C, and its therapeutic potential in sepsis-induced acute lung injury via modulation of the TLR4/TRIF/NF-κB pathway. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108779

Vancouver

Xin J, Sun Y, Huang S, Yang P, Mou X, Dai S, et al. Total synthesis of a novel C9-monoterpenoid alkaloid, Forsyqinlingine C, and its therapeutic potential in sepsis-induced acute lung injury via modulation of the TLR4/TRIF/NF-κB pathway. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108779

BibTeX
@article{Xin2025,
  author = {Xin, Jianzeng and Sun, Yupei and Huang, Shuai and Yang, Pufan and Mou, Xiaofeng and Dai, Shengjun and Du, Yuan and Liu, Sheng},
  title = {Total synthesis of a novel C9-monoterpenoid alkaloid, Forsyqinlingine C, and its therapeutic potential in sepsis-induced acute lung injury via modulation of the TLR4/TRIF/NF-κB pathway},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108779}
}
Kostenlos starten →